Amphastar Pharmaceuticals (AMPH) PT Lowered to $21 at Piper Sandler
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $20.14 -0.2%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $21.00 (from $25.00) while maintaining a Neutral rating.
You May Also Be Interested In
- SoundThinking (SSTI) PT Lowered to $8 at Cantor Fitzgerald
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
- McGraw Hill (MH) PT Raised to $15 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
